Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
In the latest session, Pulmonx Corp (NASDAQ: LUNG) closed at $7.25 down -0.68% from its previous closing price of $7.30. In other words, the price has decreased by -$0.68 from its previous closing price. On the day, 1.14 million shares were traded. LUNG stock price reached its highest trading level at $7.48 during the session, while it also had its lowest trading level at $7.18.
Ratios:
For a deeper understanding of Pulmonx Corp’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 6.13 and its Current Ratio is at 6.94. In the meantime, Its Debt-to-Equity ratio is 0.37 whereas as Long-Term Debt/Eq ratio is at 0.30.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Wells Fargo on February 23, 2024, Downgraded its rating to Equal Weight and sets its target price to $14 from $16 previously.
On September 05, 2023, Craig Hallum started tracking the stock assigning a Buy rating and target price of $18.
Wells Fargo Upgraded its Equal Weight to Overweight on February 27, 2023, whereas the target price for the stock was revised from $10 to $15.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on May 22 ’24 when Rose Geoffrey Beran sold 1,184 shares for $8.71 per share. The transaction valued at 10,313 led to the insider holds 305,500 shares of the business.
Rose Geoffrey Beran sold 1,184 shares of LUNG for $8,868 on Apr 22 ’24. The CHIEF COMMERCIAL OFFICER now owns 306,684 shares after completing the transaction at $7.49 per share. On Mar 22 ’24, another insider, Rose Geoffrey Beran, who serves as the CHIEF COMMERCIAL OFFICER of the company, sold 1,184 shares for $9.36 each. As a result, the insider received 11,082 and left with 307,868 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, LUNG now has a Market Capitalization of 281414560 and an Enterprise Value of 205856256. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.86 while its Price-to-Book (P/B) ratio in mrq is 2.55. Its current Enterprise Value per Revenue stands at 2.82 whereas that against EBITDA is -3.517.
Stock Price History:
Over the past 52 weeks, LUNG has reached a high of $14.84, while it has fallen to a 52-week low of $7.11. The 50-Day Moving Average of the stock is -13.66%, while the 200-Day Moving Average is calculated to be -30.02%.
Shares Statistics:
For the past three months, LUNG has traded an average of 505.55K shares per day and 365200 over the past ten days. A total of 38.52M shares are outstanding, with a floating share count of 35.63M. Insiders hold about 8.21% of the company’s shares, while institutions hold 90.09% stake in the company. Shares short for LUNG as of 1715731200 were 1556064 with a Short Ratio of 3.08, compared to 1713139200 on 1726649. Therefore, it implies a Short% of Shares Outstanding of 1556064 and a Short% of Float of 5.72.
